FLSM
IMVT icon

Frazier Life Sciences Management’s Immunovant IMVT Stock Holding History

Frazier Life Sciences Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300,000
Closed -$5.69M – 53
2023
Q2 		$5.69M Sell
300,000
-285,759
-49% -$5.33M 0.34% 39
2023
Q1 		$9.09M Hold
585,759
– – 0.66% 31
2022
Q4 		$10.4M Hold
585,759
– – 0.65% 30
2022
Q3 		$3.27M Hold
585,759
– – 0.25% 37
2022
Q2 		$2.28M Hold
585,759
– – 0.22% 35
2022
Q1 		$3.23M Buy
+585,759
New +$3.65M 0.28% 38

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return